NGS Sequencing for COVID-19 drug development

2.1 - Sequencage-Genome

Service description

Sequencing occurs at many stages of drug development. In the case of the COVID-19 epidemic, sequencing of the SARS-CoV2 virus that has infected patients may assess whether it has mutated or not, and patient sequencing may be relevant to determine particular resistance or susceptibility.

NGS has also been used to identify variants of the virus, (like the delta variant or the omicron variant)

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request
  • Samples to sequence

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Sequencing following the specifications validated with the Expert

Get started with your COVID-19 NGS sequencing analysis request

Please answer the fields below to be contacted by our team of scientists

section1-3
Back
home